Citations

Mayo Clinic

Showing 10 of 108522 citations.

Pregnancy‐related issues in women with systemic lupus erythematosus
Singh, Abha G., Chowdhary, Vaidehi

International Journal of Rheumatic Diseases | December 26, 2014 | Volume: 18 | Issue: 2 | Pages: 172-181

10.1111/1756-185x.12524 | PMID 25545844 Get It

AbstractWhile fertility is preserved in females with systemic lupus erythematosus (SLE), it is well established that pregnancy in these patients is associated with adverse maternal and fetal outcomes, including pregnancy loss, pre‐eclampsia, preterm delivery and intrauterine growth retardation, as well as neonatal mortality. Mechanisms underlying these adverse outcomes are poorly understood, and better understanding of these would allow development of targeted and personalized treatment strategies. Established risk factors for adverse pregnancy outcomes include active disease within 6 months prior to conception and during pregnancy, active nephritis, maternal hypertension, antiphospholipid antibodies and hypocomplementemia. While intensive monitoring is recommended, the comparative effectiveness of appropriate management strategies is unclear. While current strategies are able to achieve live births in 85–90% of pregnancies, certain aspects such as prevention of preterm birth, treatment of congenital heart block due to neonatal lupus and recurrent pregnancy loss despite best management, remains challenging. Pregnancy is also associated with an increased risk of flare of lupus, particularly in patients with active disease at time of conception or within 6 months prior to conception. Pregnant patients withSLEshould be followed in a high‐risk obstetric clinic, and care should be closely coordinated between the obstetrician and rheumatologist.
The spectrum of acute encephalitis
Singh, Tarun D. , Fugate, Jennifer E. , Rabinstein, Alejandro A.

Neurology | December 24, 2014 | Volume: 84 | Issue: 4 | Pages: 359-366

10.1212/wnl.0000000000001190 | PMID 25540320 Get It

Feasibility of Discriminating Uric Acid From Non–Uric Acid Renal Stones Using Consecutive Spatially Registered Low- and High-Energy Scans Obtained on a Conventional CT Scanner
Shiung, Maria, Qu, Mingliang , Vrtiska, Terri J., Grant, Katharine L., Krauß, Bernhard , Schmidt, Bernhard , Leng, Shuai , Ai, Songtao , Lieske, John C. , McCollough, Cynthia H.

American Journal of Roentgenology | December 24, 2014 | Volume: 204 | Issue: 1 | Pages: 92-97

10.2214/ajr.13.11911 | PMID 25539242 Get It

Cardiopulmonary bypass and intra‐aortic balloon pump use is associated with higher short and long term mortality after transcatheter aortic valve replacement: A PARTNER trial substudy
Shreenivas, Satya , Lilly, Scott , Szeto, Wilson Y. , Anwaruddin, Saif , Bavaria, Joseph E. , Hudock, Kristin , Thourani, Vinod H. , Makkar, Raj , Pichard, Augusto D., Webb, John G. , Dewey, Todd, Suri, Rakesh M. , Xu, Ke , Leon, Martin B. , Desai, Nimesh D. , Kapadia, Samir , Herrmann, Howard C.

Catheterization and Cardiovascular Interventions | December 24, 2014 | Volume: 86 | Issue: 2 | Pages: 316-322

10.1002/ccd.25776 | PMID 25546704 Get It

BackgroundTranscatheter aortic valve replacement (TAVR) with the balloon‐expandable Sapien transcatheter heart valve improves survival compared to standard therapy in patients with severe aortic stenosis (AS) and is noninferior to surgical aortic valve replacement (AVR) in patients at high operative risk. Nonetheless, a significant proportion of patients may require pre‐emptive or emergent support with cardiopulmonary bypass (CPB) and/or intra‐aortic balloon pump (IABP) during TAVR due to pre‐existing comorbid conditions or as a result of procedural complications. Objectives: We hypothesized that patients who required CPB or IABP would have increased periprocedural complications and reduced long‐term survival. In addition, we sought to determine whether preprocedural variables could predict the need for CPB and IABP. Methods: The study population included 2,525 patients in the PARTNER Trial (Cohort A and B) and the continuing access registry (CAR). Patients that received CPB or IABP were compared to patients that did not receive either, and then further divided into those that received support pre‐TAVR and those that were placed on support emergently. Results: One‐hundred sixty‐three patients (6.5%) were placed on CPB and/or IABP. The use of CPB or IABP was associated with higher 1 year mortality (49.1% vs. 21.6%, P < 0.001). In multivariable analysis, utilization of CPB or IABP was an independent predictor of 30 day (HR 6.95) and 1‐year (HR 2.56) mortality. Although mortality was highest in emergent cases, mortality was also greater in planned CPB and IABP cases compared with non‐CPB/IABP cases (53.3% and 40.3% vs. 21.6%, P < 0.001). Conclusions: These findings indicate that CPB and IABP use in TAVR portends a poor prognosis and its utilization, particularly in the setting of pre‐emptive use, needs reconsideration. © 2015 Wiley Periodicals, Inc.
Reliability of magnetic resonance elastography using multislice two‐dimensional spin‐echo echo‐planar imaging (SE‐EPI) and three‐dimensional inversion reconstruction for assessing renal stiffness
Low, Gavin , Owen, Nicola , Joubert, Ilse , Patterson, Andrew J. , Graves, Martin J. , Glaser, Kevin J. , Alexander, Graeme , Lomas, David J.

Journal of Magnetic Resonance Imaging | December 24, 2014 | Volume: 42 | Issue: 3 | Pages: 844-850

10.1002/jmri.24826 | PMID 25537823 Get It

BackgroundTo evaluate the reliability of MRE using a spin‐echo echo‐planar imaging (SE‐EPI) renal MRE technique in healthy volunteers.MethodsInstitutional review board approved prospective study in which all participants provided written informed consent. Sixteen healthy volunteers comprising seven males and nine females with a median age of 35 years (age range: 23 to 59 years) were included. Coronal 90 Hz and 60 Hz MRE acquisitions were performed twice within a 30‐min interval between examinations. Renal MRE reliability was assessed by (i) test–retest repeatability, and (ii) inter‐rater agreement between two independent readers. The MRE‐measured averaged renal stiffness values were evaluated using: intraclass correlation coefficient (ICC), Bland‐Altman and the within‐subject coefficient of variation (COV).ResultsFor test–retest repeatability, Bland‐Altman showed a mean stiffness difference between examinations of 0.07 kPa (95% limits of agreement: −1.41, 1.54) at 90 Hz and 0.01 kPa (95% limits of agreement: −0.51, 0.53) at 60 Hz. Coefficient of repeatability was 1.47 kPa and 0.52 kPa at 90 Hz and 60 Hz, respectively. The within‐subject COV was 13.6% and 7.7% at 90 Hz and 60 Hz, respectively. ICC values were 0.922 and 0.907 for test–retest repeatability and 0.998 and 0.989 for inter‐rater agreement, respectively (P < 0.001).ConclusionSE‐EPI renal MRE is a reliable technique. J. Magn. Reson. Imaging 2015;42:844–850.
Concise Review: Growing Hearts in the Right Place: On the Design of Biomimetic Materials for Cardiac Stem Cell Differentiation
Farouz, Yohan , Menasché, Philippe , Chen, Yong , Terzic, André

Stem Cells | December 24, 2014 | Volume: 33 | Issue: 4 | Pages: 1021-1035

10.1002/stem.1929 | PMID 25537366 Get It

AbstractTissue engineering aims at recapitulating permissive conditions that enable cells to collaborate and form functional tissues. Applications range from human tissue modeling for diagnostic purposes to therapeutic solutions in regenerative medicine and surgery. Across this spectrum, human stem cells are the active ingredient, expandable virtually indefinitely and with the propensity to generate new tissue. Engaging lineage-specific differentiation requires a precise concerto of key spatial and temporal factors, such as soluble molecules and growth factors, but also physical and mechanical stimuli. These stimuli compete to modulate distinct developmental signaling pathways and ultimately affect the differentiation efficiency. The heart is a chemo-mechano-electrical biological system that behaves as both a sensor and an actuator. It can transduce electrical inputs to generate mechanical contraction and electrical wave propagation. Such a complex organ arises from multipart developmental events that interact with one another to self-regulate. Here, we overview the main events of heart development and the role of mechanical forces in modifying the microenvironment of the progenitor cells. We analyze the cascades regulating cardiac gene activation to illustrate how mechanotransduction is already involved in the most popular protocols for stem cell differentiation (SCD) into cardiomyocytes. We then review how forces are transmitted to embryonic stem cells by cell-substrate or cell-cell communications, and how biomaterials can be designed to mimic these interactions and help reproduce key features of the developmental milieu. Putting this back in a clinical perspective, many challenges needs to be overcome before biomaterials-based SCD protocols can be scaled up and marketed. Stem Cells 2015;33:1021–1035
The $64,000 question
Keller, A. Scott, Schiavo, Dante , Wingo, Majken T. , Ernste, Floranne C. , Sánchez, William , Sanchez, William

Journal of Hospital Medicine | December 24, 2014 | Volume: 10 | Issue: 2 | Pages: 112-115

10.1002/jhm.2304 | PMID 25537658 Get It

Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial
Choueiri, Toni K. , Figueroa, David J. , Fay, André P. , Liu, Yuan , Gagnon, Robert , Deen, Keith C., Benson, Peter, Ho, Thai H. , Pandite, Lini , Souza, Paul de , Powles, Thomas, Motzer, Robert J. , Signoretti, Sabina , Carpenter, Christopher , Ho, Thai , Motzer, Robert J , Choueiri, Toni K

Clinical Cancer Research | December 24, 2014 | Volume: 21 | Issue: 5 | Pages: 1071-1077

10.1158/1078-0432.ccr-14-1993 | PMID 25538263 Get It

Abstract Purpose: The interaction of programmed death-1 ligand (PD-L1) with its receptor (PD-1) on T cells inactivates antitumor immune responses. PD-L1 expression has been associated with poor outcomes in renal cell carcinoma (RCC) but has not been investigated in advanced RCC patients receiving VEGF-targeted therapy. Experimental Design: Formalin-fixed paraffin-embedded specimens were collected at baseline from patients in the COMPARZ trial. Tumor cell PD-L1 expression by IHC was evaluated using H-score (HS). Dual PD-L1/CD68 staining was used to differentiate PD-L1 tumor expression from tumor-associated macrophages. Intratumor CD8-positive T cells were quantified morphometrically. Associations between biomarkers and survival were investigated using the log-rank test. Results: HS data were available from 453 of 1,110 patients. Sixty-four percent of patients had negative PD-L1 expression (HS = 0). Patients with HS &gt; 55 (n = 59, 13%) had significantly shorter overall survival (OS) than those with HS ≤ 55 in both pazopanib and sunitinib arms (median 15.1 vs. 35.6 and 15.3 vs. 27.8 months, respectively, P = 0.03). In both arms, median OS was shortest in patients with HS &gt; 55 and intratumor CD8-positive T-cell counts &gt; 300 (9.6 and 11.9 months with pazopanib and sunitinib, respectively). Median OS in patients with HS ≤ 55 and CD8-positive T-cell counts ≤ 300 was 36.8 and 28.0 months with pazopanib and sunitinib, respectively. Progression-free survival results were similar to OS results. Conclusions: Increased tumor cell PD-L1, or PD-L1 plus tumor CD8-positive T-cell counts, were associated with shorter survival in patients with metastatic RCC receiving VEGF-targeted agents. These findings may have implications for future design of randomized clinical trials in advanced RCC. Clin Cancer Res; 21(5); 1071–7. ©2014 AACR.
Pediatric Atopic Dermatitis and Associated Morbidities
Davis, Dawn Marie R. , Davis, Dawn

JAMA Dermatology | December 23, 2014 | Volume: 151 | Issue: 2 | Pages: 152

10.1001/jamadermatol.2014.3128 | PMID 25535698 Get It

Opioid induced hyperalgesia: A focus on opioid use in chronic pain
Cunningham, Julie L.

Mental Health Clinician | December 23, 2014 | Volume: 2 | Issue: 12 | Pages: 395-397

10.9740/mhc.n155462 Get It

Opioids are a well-established treatment option for chronic pain. However, opioid therapy is associated with many side effects, including opioid induced hyperalgesia (OIH). This article reviews studies which have evaluated OIH in chronic pain patients on opioids.